Interpretable machine learning model to detect chemically adulterated urine samples analyzed by high resolution mass spectrometry

Author(s):  
Gabriel L. Streun ◽  
Andrea E. Steuer ◽  
Lars C. Ebert ◽  
Akos Dobay ◽  
Thomas Kraemer

Abstract Objectives Urine sample manipulation including substitution, dilution, and chemical adulteration is a continuing challenge for workplace drug testing, abstinence control, and doping control laboratories. The simultaneous detection of sample manipulation and prohibited drugs within one single analytical measurement would be highly advantageous. Machine learning algorithms are able to learn from existing datasets and predict outcomes of new data, which are unknown to the model. Methods Authentic human urine samples were treated with pyridinium chlorochromate, potassium nitrite, hydrogen peroxide, iodine, sodium hypochlorite, and water as control. In total, 702 samples, measured with liquid chromatography coupled to quadrupole time-of-flight mass spectrometry, were used. After retention time alignment within Progenesis QI, an artificial neural network was trained with 500 samples, each featuring 33,448 values. The feature importance was analyzed with the local interpretable model-agnostic explanations approach. Results Following 10-fold cross-validation, the mean sensitivity, specificity, positive predictive value, and negative predictive value was 88.9, 92.0, 91.9, and 89.2%, respectively. A diverse test set (n=202) containing treated and untreated urine samples could be correctly classified with an accuracy of 95.4%. In addition, 14 important features and four potential biomarkers were extracted. Conclusions With interpretable retention time aligned liquid chromatography high-resolution mass spectrometry data, a reliable machine learning model could be established that rapidly uncovers chemical urine manipulation. The incorporation of our model into routine clinical or forensic analysis allows simultaneous LC-MS analysis and sample integrity testing in one run, thus revolutionizing this field of drug testing.

Author(s):  
Sarah L Belsey ◽  
Robert J Flanagan

Abstract The advent of hundreds of new compounds aimed at the substance misuse market has posed new analytical challenges. A semi-quantitative liquid chromatography–high resolution mass spectrometry (LC–HRMS) method has been developed to detect exposure to two novel stimulants, mephedrone and ethylphenidate, and selected metabolites. Centrifuged urine (50 µL) was diluted with LC eluent containing internal standards (mephedrone-d3, methylphenidate-d9, and ritalinic acid-d10, all 0.02 mg/L) (450 µL). Intra- and inter-assay accuracy and precision were within ± 15% and < 6% respectively, for all analytes. The limit of detection was 0.01 mg/L all analytes. Urine samples from mephedrone and ethylphenidate users were analyzed using immunoassay (amphetamine-group CEDIA) and LC–HRMS. Ethylphenidate, mephedrone, and selected metabolites all had low cross-reactivity (<1%) with the immunoassay. The median (range) amphetamine-group CEDIA concentration in urine samples from mephedrone users (N = 11) was 0.30 (<0.041–3.04) mg/L, with only one sample giving a positive CEDIA result. The amphetamine-group CEDIA concentration in the urine sample from an ethylphenidate user was <0.041 mg/L. Improving the detection of novel compounds is of increasing importance to enable accurate diagnosis and treatment. Immunoassay methods used for drug screening may be inappropriate and lead to false negative results. Conversely, detection of these compounds is possible through use of LC–HRMS and can provide information on the metabolites present after exposure to these drugs.


Sign in / Sign up

Export Citation Format

Share Document